1643.HKライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (2 5月 2024 @ 15:25):

Modern Chinese Medicine Group Co., Ltd., an investment holding company, produces and sells proprietary Chinese medicines for elderlies and aged-middle in the People's Republic of China...

Stats
本日の出来高	1.06M
平均出来高	311 543
時価総額	183.00M
Last Dividend	HKD0.0167 ( 2022-05-25 )
Next Dividend	HKD0 ( N/A )
P/E	3.39
ATR14	HKD0 (0.00%)

Modern Chinese Medicine 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Modern Chinese Medicine 財務諸表

Annual	2023
収益:	HKD344.08M
総利益:	HKD104.18M (30.28 %)
EPS:	HKD0.0813

FY	2023
収益:	HKD344.08M
総利益:	HKD104.18M (30.28 %)
EPS:	HKD0.0813

FY	2022
収益:	HKD399.66M
総利益:	HKD170.79M (42.73 %)
EPS:	HKD0.150

Financial Reports:

No articles found.

Modern Chinese Medicine Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Modern Chinese Medicine Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.94 - Potential for dividend initiation, but uncertain (1.11%)

Information

First Dividend	HKD0.0167	2022-05-25
Last Dividend	HKD0.0167	2022-05-25
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	HKD0.0167	--
Avg. Dividend % Per Year	0.00%	--
Score	2.32	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.94
Div. Directional Score	7.71	--

Next Divdend (Est)
(2024-05-02)

HKD0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

2.32

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8490.HK	No Dividend Player	2023-06-23	Annually	0.00%
2096.HK	Ex Dividend Junior	2023-06-19	Annually	0.00%
1110.HK	Ex Dividend Junior	2023-06-01	Annually	0.00%
0175.HK	Ex Dividend Knight	2023-06-05	Annually	0.00%
3798.HK	Ex Dividend Knight	2023-06-01	Annually	0.00%
1686.HK	Ex Dividend Junior	2023-10-31	Annually	0.00%
0719.HK	Ex Dividend Knight	2023-07-07	Annually	0.00%
2238.HK	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
1258.HK	Ex Dividend Knight	2023-06-30	Annually	0.00%
0317.HK	Ex Dividend Junior	2023-05-29	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.159	1.500	6.83	10.00	[0 - 0.5]
returnOnAssetsTTM	0.183	1.200	3.90	4.69	[0 - 0.3]
returnOnEquityTTM	0.209	1.500	8.79	10.00	[0.1 - 1]
payoutRatioTTM	0.00736	-1.000	9.93	-9.93	[0 - 1]
currentRatioTTM	8.93	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	7.96	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	5.86	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	9 967.60	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	0.127	2.00	9.96	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.104	2.00	9.95	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.344	1.000	7.60	7.60	[0.2 - 0.8]
operatingProfitMarginTTM	0.239	1.000	7.23	7.23	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	1.153	0.800	5.65	4.52	[0.5 - 2]
Total Score				10.49

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	1.987	1.000	9.90	0	[1 - 100]
returnOnEquityTTM	0.209	2.50	9.22	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.104	2.00	9.97	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.127	2.00	9.96	10.00	[0 - 30]
payoutRatioTTM	0.00736	1.500	9.93	-9.93	[0 - 1]
pegRatioTTM	-0.484	1.500	-6.56	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.125	1.000	9.39	0	[0.1 - 0.5]
Total Score				4.94

Modern Chinese Medicine

Modern Chinese Medicine Group Co., Ltd., an investment holding company, produces and sells proprietary Chinese medicines for elderlies and aged-middle in the People's Republic of China. It offers therapeutics for the qi-deficiency and blood-statis, cardio-cerebrovascular, digestive and gastrointestinal, gynecological, respiratory system, and nervous system conditions. The company was founded in 1986 and is headquartered in Chengde, China. Modern Chinese Medicine Group Co., Ltd. is a subsidiary of Modern Biotechnology Group Holdings Co., Ltd.